Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases-Reference-Cited by-同舟云学术

Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases

Published:2016-04-30 Issue:13 Volume:46 Page:1402-1408
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Nakano Norihito¹,Kawaoka Tomokazu¹,Aikata Hiroshi¹,Honda Fumi¹,Nakamura Yuki¹,Morio Kei¹,Hatooka Masahiro¹,Fukuhara Takayuki¹,Kobayashi Tomoki¹,Hiramatsu Akira¹,Imamura Michio¹,Kawakami Yoshiiku¹,Takahashi Shoichi¹,Chayama Kazuaki¹

Affiliation:

1. Department of Medicine and Molecular Science; Division of Frontier Medical Science, and, Hiroshima University; Hiroshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12698/fullpdf

Reference36 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

3. Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib;Shiba;Hepatol Res,2014

4. Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: a case report;So;J Hematol Oncol,2008

5. Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib;Yeganeh;Am J Transplant,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alagille syndrome and hepatocellular carcinoma in a non-cirrhotic adult;Medicina Clínica (English Edition);2022-03

2. Síndrome de Alagille y carcinoma hepatocelular en adulto no cirrótico;Medicina Clínica;2021-07

3. A case report: Long-term complete response of metastatic hepatocellular carcinoma obtained after discontinuation of 2-month sorafenib monotherapy;Clinical Journal of Gastroenterology;2020-06-15

4. Long-term sustained complete response with off-therapy to sorafenib in advanced hepatocellular carcinoma: a case report;Kanzo;2020-05-01

5. Complete Response Using Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma with Multiple Lymph Node and Bone Metastases: A Case Report;The Showa University Journal of Medical Sciences;2019